Literature DB >> 871633

Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.

H Ikram.   

Abstract

Haemodynamic studies were performed in 10 patients with uncomplicated thyrotoxicosis and seven with thyrotoxic cardiac failure. The cardiac output of those with uncomplicated hyperthyroidism was higher than normal at rest. After 2 mg of intravenous propranolol there was a 13% fall but the level was still higher than normal. In patients with thyrotoxic cardiac failure the resting cardiac output was normal, but it fell after propranolol by 30% to subnormal levels. In both groups there was an increase in right heart pressures and fall in the rate of increase in arterial pressure, which indicated a decrease in myocardial contractility. These results indicate that increased autonomic activity is a compensatory phenomenon in hyperthyroid heart failure and that its abolition by beta-blocking drugs has a deleterious effect on cardiac function. They are therefore contraindicated in patients with thyrotoxic heart failure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871633      PMCID: PMC1607258          DOI: 10.1136/bmj.1.6075.1505

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  20 in total

1.  PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

Authors:  W R WILSON; E O THEILEN; F W FLETCHER
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  GUANETHIDINE IN HYPERTHYROIDISM.

Authors:  S S WALDSTEIN; G H WEST; W Y LEE; D BRONSKY
Journal:  JAMA       Date:  1964-08-24       Impact factor: 56.272

3.  CATECHOLAMINE DEPLETION IN THYROTOXICOSIS. EFFECT OF GUANETHIDINE ON CARDIOVASCULAR DYNAMICS.

Authors:  S GOLDSTEIN; T KILLIP
Journal:  Circulation       Date:  1965-02       Impact factor: 29.690

4.  The acute hemodynamic effects of alpha-methyldopa in thyrotoxic patients and normal subjects.

Authors:  E O THEILEN; W R WILSON; F J TUTUNJI
Journal:  Metabolism       Date:  1963-07       Impact factor: 8.694

5.  Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

Authors:  J J CANARY; M SCHAAF; B J DUFFY; L H KYLE
Journal:  N Engl J Med       Date:  1957-09-05       Impact factor: 91.245

6.  Catheter replacement of the needle in percutaneous arteriography; a new technique.

Authors:  S I SELDINGER
Journal:  Acta radiol       Date:  1953-05       Impact factor: 1.990

7.  Use of a computer in the calibration of dye dilution curves by a dynamic method.

Authors:  J Hamer; R Emanuel; J Norman; M Burgess
Journal:  Br Heart J       Date:  1966-03

8.  Influence of beta sympathetic blockade (propranolol) on the hemodynamics of hyperthyroidism.

Authors:  L Wiener; B D Stout; J W Cox
Journal:  Am J Med       Date:  1969-02       Impact factor: 4.965

9.  Beta-sympathetic blockade in hyperthyroidism.

Authors:  G Howitt; D J Rowlands
Journal:  Lancet       Date:  1966-03-19       Impact factor: 79.321

10.  A comparative study of nitroglycerin and propranolol.

Authors:  E Robin; C Cowan; P Puri; S Ganguly; E DeBoyrie; M Martinez; T Stock; R J Bing
Journal:  Circulation       Date:  1967-08       Impact factor: 29.690

View more
  10 in total

1.  Heart failure in thyrotoxicosis, an approach to management.

Authors:  R P Choudhury; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  Verapamil in atrial fibrillation in hyperthyroidism.

Authors:  C G Dahlstrøm; S D Ladefoged
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-30

3.  Left ventricular function and hyperthyroidism.

Authors:  J P Merillon; P Passa; J Chastre; A Wolf; R Gourgon
Journal:  Br Heart J       Date:  1981-08

4.  Hemodynamic and tissue oxygenation responses to exercise and beta-adrenergic blockade in patients with hyperthyroidism.

Authors:  Maristela C Monachini; Silvia G Lage; Miguel A N Ran; Rita H A Cardoso; Caio Medeiros; Bruno Caramelli; Andrei C Sposito; José A F Ramires
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

Review 5.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

6.  Delayed recovery of left ventricular function after antithyroid treatment. Further evidence for reversible abnormalities of contractility in hyperthyroidism.

Authors:  J C Forfar; D M Matthews; A D Toft
Journal:  Br Heart J       Date:  1984-08

Review 7.  Hyperthyroidism. Current drug therapy.

Authors:  J R Stockigt; D J Topliss
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

8.  Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease.

Authors:  Raphael C Anakwue; Basden J Onwubere; Vincent Ikeh; Benedict Anisiuba; Samuel Ike; Angel-Mary C Anakwue
Journal:  Ther Clin Risk Manag       Date:  2015-02-05       Impact factor: 2.423

9.  Propranolol-Induced Circulatory Collapse in a Patient With Thyroid Crisis and Underlying Thyrocardiac Disease: A Word of Caution.

Authors:  Hossam Abubakar; Vijendra Singh; Anandita Arora; Sammar Alsunaid
Journal:  J Investig Med High Impact Case Rep       Date:  2017-12-20

10.  Management of Cardiogenic Shock due to Thyrotoxicosis: A Systematic Literature Review.

Authors:  Milad Modarresi; Ahmed Amro; Mohammad Amro; Amal Sobeih; Uzo Okoro; Kanaan Mansoor; Carlos Rueda; Rawan Elhamdani; Nesreen BenHamed; Timothy Kocher; Mehiar Elhamdani
Journal:  Curr Cardiol Rev       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.